Magnetar Financial LLC Regeneron Pharmaceuticals, Inc. Transaction History

Magnetar Financial LLC

  • $3.44 Billion
  • Q3 2024

A detailed history of Magnetar Financial LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Magnetar Financial LLC holds 7,000 shares of REGN stock, worth $5.48 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
7,000
Holding current value
$5.48 Million
% of portfolio
0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $7.17 Million - $8.41 Million
7,000 New
7,000 $7.36 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $30 Million - $33 Million
33,257 New
33,257 $32 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $47.8 Million - $56.7 Million
68,320 New
68,320 $49.1 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $2.75 Million - $3.47 Million
4,794 Added 1044.44%
5,253 $3.62 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $251,692 - $339,127
459 New
459 $271,000
Q2 2021

Aug 06, 2021
SELL
$472.8 - $558.54 $2.76 Million - $3.26 Million
-5,832 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $1.23 Million - $1.51 Million
2,752 Added 89.35%
5,832 $2.76 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $38,264 - $48,638
-80 Reduced 2.53%
3,080 $1.49 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $1.72 Million - $2.08 Million
3,160 New
3,160 $1.77 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $335,535 - $390,664
-1,227 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $178,561 - $247,232
-596 Reduced 32.69%
1,227 $384,000
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $678,301 - $801,336
1,823 New
1,823 $749,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $272,014 - $326,462
-810 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $205,416 - $238,978
-585 Reduced 41.94%
810 $327,000
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $578,828 - $758,499
-1,614 Reduced 53.64%
1,395 $524,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $1.3 Million - $1.52 Million
3,009
3,009 $1.35 Million

Others Institutions Holding REGN

# of Institutions
1,524
Shares Held
84M
Call Options Held
1.14M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email